`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`
`
`Case No.: 1:23-CV-11573
`
`
`
`
`Plaintiffs,
`
`
`v.
`
`
`GENENTECH, INC., HOFFMANN-LA
`ROCHE, INC., and CHUGAI
`PHARMACEUTICAL CO., LTD,
`
`
`
`
`BIOGEN MA INC and BIO-THERA
`SOLUTIONS, LTD.,
`
`
`
`
`
`
`Defendants.
`
`
`
`
`
`JOINT STIPULATION REGARDING ACCEPTANCE OF SERVICE OF COMPLAINT
`AND DEADLINE FOR RESPONSE TO COMPLAINT
`
`Plaintiffs Genentech, Inc., Hoffmann-La Roche, Inc. and Chugai Pharmaceutical Co.,
`
`Ltd. (collectively, “Plaintiffs”) and Defendants Biogen MA Inc. and Bio-Thera Solutions, Ltd.
`
`(collectively, “Defendants”), hereby stipulate as follows:
`
`WHEREAS, Plaintiffs filed a Complaint against Defendants on July 13, 2023, seeking a
`
`judgment of patent infringement against Defendants under 35 U.S.C. § 271(e);
`
`WHEREAS, Plaintiffs contend that Defendant Biogen MA Inc. was served with the
`
`summons and Complaint on July 17, 2023 and that its response is currently due by August 7,
`
`2023;
`
`WHEREAS, Defendant Biogen MA Inc. contends that it was not properly served with the
`
`summons and Complaint;
`
`WHEREAS, Plaintiffs provided a courtesy copy of the Complaint to Defendant Bio-
`
`Thera Solutions, Ltd.’s counsel via electronic mail on July 17, 2023;
`
`
`
`
`
`1
`
`
`
`Case 1:23-cv-11573-LTS Document 8 Filed 08/07/23 Page 2 of 5
`
`
`
`WHEREAS, undersigned counsel for Defendant Bio-Thera Solutions, Ltd. have agreed to
`
`waive formal service of process on behalf of Defendant Bio-Thera Solutions, Ltd. as part of this
`
`Stipulation;
`
`WHEREAS, undersigned counsel for Defendant Biogen MA Inc. have agreed to waive
`
`formal service of process on behalf of Defendant Biogen MA Inc. as part of this Stipulation;
`
`WHEREAS, the parties have conferred and agreed, subject to approval of the Court, to
`
`make October 3, 2023 the deadline for Defendant Biogen MA Inc. and Defendant Bio-Thera
`
`Solutions, Ltd. to answer, move, or otherwise respond to the Complaint;
`
`NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED, subject to
`
`approval of the Court, that:
`
`1.
`
`Defendant Biogen MA Inc. hereby accepts service of the summons and the
`
`Complaint in the above-captioned matter and waives the formal service requirements set forth in
`
`Rule 4 of the Federal Rules of Civil Procedure and any applicable local rules of this Court,
`
`including, but not limited to, service of a summons.
`
`2.
`
`Defendant Bio-Thera Solutions, Ltd. hereby accepts service of the summons and
`
`the Complaint in the above-captioned matter and waives the formal service requirements set
`
`forth in Rule 4 of the Federal Rules of Civil Procedure and any applicable local rules of this
`
`Court, including, but not limited to, service of a summons.
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`Case 1:23-cv-11573-LTS Document 8 Filed 08/07/23 Page 3 of 5
`
`
`
`3.
`
` Biogen MA Inc. and Bio-Thera Solutions, Ltd. shall answer, move, or otherwise
`
`respond to the Complaint on or before October 3, 2023.
`
`
`Date: August 7, 2023
`
`
`
`
`
`/s/ Benjamin M. Stern
`Nelson G. Apjohn (BBO# 020373)
`Benjamin M. Stern (BBO #646778)
`Nutter McClennen & Fish LLP
`155 Seaport Blvd
`Boston, MA 02210
`(617) 439-2246
`napjohn@nutter.com
`bstern@nutter.com
`
`Paul B. Gaffney (pro hac vice forthcoming)
`Thomas S. Fletcher (pro hac vice forthcoming)
`Emma J. Nino (pro hac vice forthcoming)
`Kristin L. Froehle (pro hac vice forthcoming)
`Ian M. Swenson (pro hac vice forthcoming)
`Jacob L. Burnett (pro hac vice forthcoming)
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, SW
`Washington, DC 20024
`(202) 434-5000
`pgaffney@wc.com
`tfletcher@wc.com
`enino@wc.com
`kfroehle@wc.com
`iswenson@wc.com
`jburnett@wc.com
`
`Attorneys for Plaintiffs Genentech, Inc.,
`Hoffmann-La Roche, Inc., and
`Chugai Pharmaceutical Co., Ltd
`
`
`
`
`
`3
`
`
`
`
`
`
` /s/ Anita M.C. Spieth
`Eric J. Marandett (BBO# 561730)
`Anita M.C. Spieth (BBO# 676302)
`Choate, Hall & Stewart LLP
`Two International Place
`Boston, MA 02110
`(617) 248-5000
`emarandett@choate.com
`aspieth@choate.com
`
`Keith Hummel
`Sharonmoyee Goswami
`CRAVATH, SWAINE & MOORE LLP
`825 Eighth Avenue
`New York, NY 10019
`(212) 474-1928
`sgoswami@cravath.com
`khummel@cravath.com
`
`Attorneys for Defendant Biogen MA Inc.
`
`
`
`/s/ Charles L. Solomont
`Charles L. Solomont (BBO # 557190)
`Morgan, Lewis & Bockius LLP
`One Federal Street
`Boston, MA 02110-1726
`(617) 341-7700
`carl.solomont@morganlewis.com
`
`
`
`
`
`
`
`
`
`
`
`Case 1:23-cv-11573-LTS Document 8 Filed 08/07/23 Page 4 of 5
`
`
`
`Michael J. Abernathy (pro hac vice
`forthcoming)
`Shon Lo (pro hac vice forthcoming)
`MORGAN, LEWIS & BOCKIUS LLP
`110 North Wacker Drive
`Chicago, IL 60606
`(312) 324-1000
`mike.abernathy@morganlewis.com
`Shon.lo@morganlewis.com
`
`Olga Berson, Ph.D. (pro hac vice
`forthcoming)
`2049 Century Park East, Suite 700
`Los Angeles, CA 90067-3109
`(310) 907-1000
`olga.berson@morganlewis.com
`
`Attorneys for Defendant Bio-Thera
`Solutions, Ltd.
`
`
`
`
`
`IT IS SO ORDERED:
`
`
`
`Dated: _________________
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`_____________________________
`The Honorable Leo T. Sorokin
`
`
`
`4
`
`
`
`Case 1:23-cv-11573-LTS Document 8 Filed 08/07/23 Page 5 of 5
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on August 7, 2023, a true copy of the above document, including
`
`attachments, was served via electronic means using the Court’s Electronic Case Filing (ECF)
`system upon all registered ECF users, and paper copies will be sent to those indicated as non-
`registered participants.
`
`
`
`
`
`
`
`
`
`
`/s/ Benjamin M. Stern
`Benjamin M. Stern
`
`
`
`
`6125252
`
`5
`
`